BeStock  

Guardant Health GH

$176.31 −$2.05 (-1.15%)
Market open · Oct 1, 1:20 pm ET · After hours $179.00 +0.36%
Open$179.30
Prev close$178.36
Day range$175.49 – $180.91
Volume823.8K
Market cap$23.66B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$334.98M+44.3% YoY
Operating profit-$129.12M-21.3% YoY
Net profit-$120.14M-20.3% YoY
Diluted EPS-$0.90-12.5% YoY
Free cash flow-$69.54M-5.5% YoY
Operating cash flow-$57.78M

Revenue, last 8 quarters

$191.5MSep '24$201.8MDec '24$203.5MMar '25$232.1MJun '25$265.2MSep '25$281.3MDec '25$301.7MMar '26$335.0MJun '26

Net profit, last 8 quarters

$-107.8MSep '24$-111.0MDec '24$-95.2MMar '25$-99.9MJun '25$-92.7MSep '25$-128.5MDec '25$-112.1MMar '26$-120.1MJun '26

Diluted EPS by quarter

-0.88Sep '24-0.90Dec '24-0.77Mar '25-0.80Jun '25-0.74Sep '25-1.00Dec '25-0.85Mar '26-0.90Jun '26

Free cash flow by quarter

$-55.3MSep '24$-83.4MDec '24$-67.1MMar '25$-65.9MJun '25$-45.8MSep '25$-54.2MDec '25$-71.2MMar '26$-69.5MJun '26

Annual revenue

$286.7MFY20$373.7MFY21$449.5MFY22$563.9MFY23$739.0MFY24$982.0MFY25

Profitability & balance sheet

Gross margin65.0%
Operating margin-39.7%
Net margin-38.3%
Return on assets-28.0%
Current ratio4.03
Liabilities / assets111.7%
Cash & investments$1.05B
Total debt$1.67B
Net cash (debt)-$615.79M

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $334.98M $301.67M $982.02M $281.27M $265.20M
Total Operating Revenue $334.98M $301.67M $982.02M $281.27M $265.20M
Cost of Revenue $115.95M $104.92M $349.01M $99.49M $93.59M
Gross Profit $219.03M $196.75M $633.01M $181.77M $171.61M
Operating Expense $348.15M $318.10M $1.07B $302.58M $270.60M
Selling and Admin Expenses $251.61M $227.06M $706.07M $204.32M $180.64M
-Selling & Marketing Expense $189.95M $169.13M $494.66M $143.38M $127.38M
-General & Admin Expense $61.66M $57.93M $211.41M $60.93M $53.27M
Research & Development $96.53M $91.04M $364.19M $98.26M $89.96M
Operating Profit -$129.12M -$121.35M -$437.25M -$120.81M -$98.99M
Net Non-Operating Interest Income (Expense) $8.85M $9.80M $30.20M $8.85M $6.45M
Non-Operating Interest Income $10.20M $11.15M $34.10M $10.03M $7.39M
Non-Operating Interest Expense $1.35M $1.35M $3.90M $1.18M $943,000.00
Other Income (Expense) $308,000.00 -$157,000.00 -$10.49M -$18.27M -$48,000.00
Other Non-Operating Income (Expenses) $308,000.00 -$157,000.00 -$10.49M -$18.27M -$48,000.00
Pretax Profit -$119.96M -$111.70M -$417.54M -$130.22M -$92.59M
Tax $185,000.00 $372,000.00 -$1.26M -$1.73M $136,000.00
Net Profit -$120.14M -$112.08M -$416.28M -$128.49M -$92.73M
Profit from Continuing Operations -$120.14M -$112.08M -$416.28M -$128.49M -$92.73M
Net Income to Parent Company -$120.14M -$112.08M -$416.28M -$128.49M -$92.73M
Net Income to Common Stockholders -$120.14M -$112.08M -$416.28M -$128.49M -$92.73M
Basic EPS -$0.90 -$0.85 -$3.32 -$1.00 -$0.74
Diluted EPS -$0.90 -$0.85 -$3.32 -$1.00 -$0.74

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $1.91B $1.92B $2.01B $2.01B $1.28B
Total Current Assets $1.36B $1.37B $1.47B $1.47B $828.89M
Cash and Cash Equivalents & Short-Term Investments $1.05B $1.10B $1.20B $1.20B $580.01M
-Cash and Cash Equivalents $1.05B $989.29M $378.20M $378.20M $580.01M
-Short Term Investments $0.00 $113.47M $823.40M $823.40M $0.00
Receivables $144.25M $137.40M $137.85M $137.85M $115.59M
-Accounts Receivable $140.15M $131.20M $132.65M $132.65M $110.49M
-Other Receivables $4.10M $6.20M $5.20M $5.20M $5.10M
Inventory $105.46M $83.85M $85.88M $85.88M $90.49M
Other Current Assets $61.46M $43.49M $40.72M $40.72M $42.80M
Total Non-Current Assets $547.66M $547.79M $547.61M $547.61M $447.90M
Net PPE $302.87M $303.94M $304.76M $304.76M $288.16M
-Gross PPE $517.24M $508.94M $503.67M $503.67M $479.48M
-Accumulated Depreciation -$214.37M -$205.00M -$198.90M -$198.90M -$191.32M
Goodwill and Other Intangible Assets $102.52M $102.80M $103.18M $103.18M $8.77M
-Goodwill $77.26M $77.26M $77.26M $77.26M $3.29M
-Other Intangible Assets $25.27M $25.54M $25.92M $25.92M $5.48M
Other Non-Current Assets $142.27M $141.05M $139.67M $139.67M $150.98M
Total Liabilities $2.14B $2.10B $2.11B $2.11B $1.63B
Total Current Liabilities $338.96M $292.15M $302.73M $302.73M $236.92M
Payables $93.51M $75.03M $54.44M $54.44M $20.14M
-Accounts Payable $93.51M $75.03M $54.44M $54.44M $20.14M
Current Accrued Expenses $51.53M $49.98M $50.21M $50.21M $45.31M
Short-Term Debt and Capital Lease Obligation $27.76M $28.03M $27.68M $27.68M $26.40M
-Current Capital Lease Obligation $27.76M $28.03M $27.68M $27.68M $26.40M
Current Deferred Liabilities $44.79M $47.77M $50.75M $50.75M $46.86M
Total Non-Current Liabilities $1.80B $1.80B $1.81B $1.81B $1.39B
Long Term Debt and Capital Lease Obligation $1.67B $1.68B $1.68B $1.68B $1.30B
-Long Term Debt $1.50B $1.50B $1.50B $1.50B $1.11B
-Long Term Capital Lease Obligation $166.31M $173.06M $178.46M $178.46M $185.39M
Other Non-Current Liabilities $126.94M $127.69M $127.77M $127.77M $94.36M
Total Equity -$222.87M -$181.07M -$99.31M -$99.31M -$354.47M
Stockholders' Equity -$222.87M -$181.07M -$99.31M -$99.31M -$354.47M
Capital Stock $1,000.00 $1,000.00 $1,000.00 $1,000.00 $1,000.00
-Common Stock $1,000.00 $1,000.00 $1,000.00 $1,000.00 $1,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $3.01B $2.93B $2.90B $2.90B $2.56B
Retained Earnings -$3.23B -$3.11B -$2.99B -$2.99B -$2.87B
Gains/Losses Not Affecting Retained Earnings -$5.56M -$5.15M -$4.85M -$4.85M -$4.26M
Less: Treasury Stock – – – – $45.01M

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow -$57.78M -$65.62M -$184.76M -$26.37M -$35.41M
Net cash flow from continuing operations -$57.78M -$65.62M -$184.76M -$26.37M -$35.41M
Net Income from Continuing Operations -$120.14M -$112.08M -$416.28M -$128.49M -$92.73M
Depreciation & Depletion & Amortization $9.56M $9.44M $39.74M $10.05M $9.41M
Other Non-Cash Items $10.33M $19.66M $40.96M $8.89M $7.44M
Change in Working Capital -$14.26M -$23.27M -$14.43M $32.29M -$3.14M
-Change in Receivables -$6.89M $942,000.00 -$28.18M -$22.20M $14.45M
-Change in Inventory -$21.61M $2.03M -$14.79M $4.61M -$6.43M
-Change in Prepaid Assets -$16.96M -$7.24M -$6.35M $2.25M -$1.33M
-Change in Payables and Accrued Expense $44.29M -$8.23M $52.75M $53.75M $3.28M
-Change in Other Current Assets $899,000.00 $1.06M $212,000.00 -$567,000.00 -$306,000.00
-Change in Other Current Liabilities -$9.26M -$8.60M -$37.52M -$9.50M -$9.20M
-Change In Other Working Capital -$4.73M -$3.23M $19.46M $3.95M -$3.61M
Net cash flow from investing $101.47M $699.42M -$627.20M -$905.07M -$14.35M
Net Cash Flow from Continuing Investing Activities $101.47M $699.42M -$627.20M -$905.07M -$14.35M
Net PPE Purchase and Sale -$11.76M -$5.58M -$48.31M -$27.85M -$10.35M
Net Investment Purchase and Sale $113.23M $705.00M -$519.91M -$818.23M -$4.00M
Financing Cash Flow $23.01M -$21.58M $671.13M $732.03M $4.33M
Net Cash Flow from Continuing Financing Activities $23.01M -$21.58M $671.13M $732.03M $4.33M
Net Issuance Payments Of Debt -$1.43M $0.00 $402.50M $397.47M $44,000.00
Net Common Stock Issuance $0.00 $0.00 $299.99M $345.00M $0.00
Proceeds from Stock Option Exercised $28.29M $3.65M $32.81M $19.08M $3.72M
Net Other Financing Charges -$3.84M -$25.23M -$64.17M -$29.52M $566,000.00
Ending Cash Balance $1.17B $1.10B $489.42M $489.42M $689.52M
Net Change in Cash $66.71M $612.22M -$140.83M -$199.41M -$45.43M
Beginning Cash Balance $1.10B $489.42M $629.76M $689.52M $735.48M
Effect of Exchange Rate Changes -$411,000.00 -$194,000.00 $491,000.00 -$686,000.00 -$533,000.00
Free Cash Flow -$69.54M -$71.20M -$233.07M -$54.22M -$45.76M
Gain/Loss from Continuing Operations – – -$13.67M $0.00 $0.00
Net Business Purchase and Sale – – -$58.99M – –

Discussion

No comments yet — be the first to weigh in on GH.

Leave a comment

Scroll to Top